EZH2 and neoplasm: We hypothesize that the high plasticity of RMC in conjunction with EZH2 inhibition by tazemetostat allowed tumor cells to metastasize to the CNS by acquiring a glial phenotype imparting a survival advantage in the unique milieu of the cerebellum.